Herborex Biotech Impex Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 20.25%
- Profit Growth 72.53%
- Ebitda 127.43%
- Net Worth -0.08%
- Total Assets 1.90%
About Herborex Biotech Impex
Herborex Biotech Impex Private Limited (HBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 November 2004 and has a history of 20 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Mehmood, Mohammad Shahid, and Suryaveer Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239DL2004PTC130622
-
Company No.
130622
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Nov 2004
-
Date of AGM
30 Nov 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Herborex Biotech Impex?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Mehmood
|
Whole-Time Director | 19-Nov-2004 | Current |
|
Mohammad Shahid
|
Director | 23-Mar-2015 | Current |
|
Suryaveer Singh
|
Director | 06-Aug-2011 | Current |
Financial Performance of Herborex Biotech Impex.
Herborex Biotech Impex Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 20.25% increase. The company also saw a substantial improvement in profitability, with a 72.53% increase in profit. The company's net worth dipped by a decrease of 0.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herborex Biotech Impex?
In 2018, Herborex Biotech Impex had a promoter holding of 91.67% and a public holding of 8.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hamza Overseas Private LimitedMohammad Shahid is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Herborex Biotech Impex?
Unlock and access historical data on people associated with Herborex Biotech Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herborex Biotech Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herborex Biotech Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
